Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Numerous ICU Deaths Have Missed Diagnoses

By HospiMedica International staff writers
Posted on 15 Jan 2013
A new study suggests that more than a quarter of adult patients in intensive care units (ICUs) each year die with a misdiagnosis, including those with a potentially fatal major missed diagnosis.

Researchers at Johns Hopkins University (JHU; Baltimore, MD, USA) conducted a systematic meta-analysis of 31 studies that examined autopsy-confirmed diagnostic errors in the adult ICU; a median of 43% of the deaths that occurred during the study period were autopsied. More...
In all, 5,863 autopsies were abstracted for autopsy rate, misdiagnosis prevalence, Goldman error class, and diseases misdiagnosed. Studies analyzing misdiagnosis of one specific disease were excluded. The prevalence of Class I (potentially lethal) misdiagnoses were calculated as a nonlinear function of the autopsy rate.

The results showed that the prevalence of misdiagnoses ranged from 5.5–100%, with 28% of autopsies reporting at least one misdiagnosis and 8% identifying a Class I diagnostic error, such as pulmonary embolism (PE) or myocardial infarction (MI). The projected prevalence of Class I misdiagnoses for a hypothetical autopsy rate of 100% was 6.3%. Vascular events and infections were the leading lethal misdiagnoses (41% each). The most common individual Class I misdiagnoses were PE, MI, pneumonia, and aspergillosis. The study was published in the November 2012 issue of BMJ Quality and Safety.

“The 8% rate of major and potentially lethal ICU misdiagnoses is higher than the 5% rate of lethal misdiagnoses documented in the general hospital population,” said lead author Bradford Winters, MD, PhD, an associate professor of anesthesiology and critical care medicine. “The difference can be attributed to ICU-specific factors such as the inability of patients to communicate their medical history during the workup process and limited staff resources leading to ‘competition for care’.”

The Goldman Classification, widely used for autopsy findings, defines class I errors as “missed major misdiagnoses with potential adverse impact on survival and that would have changed management.” Class II errors are defined as missed major diagnoses that would not have affected survival or altered the course of care. Class III and class IV errors are defined as misdiagnoses related to the terminal disease but not related to death or unrelated to both disease and death, respectively.

Related Links:
Johns Hopkins University



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.